Microsoft's Windows 11 SE is on its way out. This move comes five years after it first hit the market. The idea was to give schools a cheap alternative to Google's Chromebooks. But it looks like Microsoft is throwing in the towel. Windows 11 SE was only for schools. It was meant to keep them from s
Mitochondria are like tiny powerhouses inside our cells. They keep us going, but sometimes they go wrong and cause problems. Tiny molecules called miRNAs help control these powerhouses. Scientists have been trying to find ways to see and fix these miRNAs to help treat diseases like cancer. A new id
In the world of environmental tech, a new hero has emerged: a clever fabric that can separate oil from water and keep tabs on its own performance. This isn't just any fabric; it's a high-tech, two-layered membrane that's changing the game. The big deal here is that this fabric can do two things at
The healthcare system is under pressure as the population ages. Hospitals are often overcrowded, and seniors frequently find themselves in a revolving door of visits. But what if technology could change this? Remote patient monitoring (RPM) is a tool that could help. It allows doctors to keep an eye
Athletes often use their own feelings to measure how hard they train. This is called a subjective scale. It is easy to use and can be a good addition to more scientific methods. But how reliable is it? A recent study looked at how well rowers can rate their own effort during training. The study foc
Mosquitoes, especially the Aedes aegypti, are spreading fast. They carry diseases and love warm weather. Scientists in central India studied how heat affects these mosquitoes. They looked at how temperature changes their growth, survival, and even how they reproduce. The study focused on mosquitoes
In the world of research funding, a new idea is being put to the test. What if the people applying for grants also got to review the applications of others? This is called distributed peer review. It's a way to get more researchers involved in deciding who gets funding. Some folks are trying this o
Mario Cazzola has taken on a new role as an honorary editor for the journal Pulmonary Pharmacology & Therapeutics. This is a big deal because it means he gets to help shape the future of research in this field. But what does this really mean for the world of respiratory medicine? First, let's talk
Heart health is a big deal, and keeping tabs on blood pressure is key. But current wearables? They're not always reliable. Enter a fresh idea: using light and sensors to monitor blood flow in your fingertip. This isn't your average tech. It's clever. It can tweak itself, so you don't have to fuss wi
In the Moscow Region, doctors are using new drugs to help people with high cholesterol. These drugs are called PCSK-9 inhibitors (alirocumab and evolocumab) and inclisiran. They work in different ways to lower cholesterol levels. Researchers looked at how many people might need these drugs. They fo
